🇺🇸 FDA
Patent

US 8440787

Hydroxyapatite-targeting multiarm polymers and conjugates made therefrom

granted A61KA61K47/24A61K47/548

Quick answer

US patent 8440787 (Hydroxyapatite-targeting multiarm polymers and conjugates made therefrom) held by Nektar Therapeutics expires Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue May 14 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K47/24, A61K47/548, A61K47/58, A61K47/60